HOSPIRA | Pfizer | workplace safety or health violation | 2006 | OSHA | $6,750 |
PFIZER, INC. | Pfizer | workplace safety or health violation | 2009 | OSHA | $7,155 |
PFIZER, INC. | Pfizer | workplace safety or health violation | 2012 | OSHA | $9,600 |
PFIZER INC / GROTON SITE | Pfizer | environmental violation | 2005 | EPA | $22,500 |
PFIZER GLOBAL MANUFACTURING | Pfizer | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
WYETH PHARMACEUTICALS COMPANY - OTC | Pfizer | water pollution violation | 2000 | EPA | $25,000 |
PHARMACIA & UPJOHN CARIBE | Pfizer | environmental violation | 2001 | EPA | $27,168 |
SEARLE LTD | Pfizer | hazardous waste violation | 2002 | EPA | $95,000 |
Pfizer Pharmaceuticals Ltd. | Pfizer | water pollution violation | 2004 | EPA | $20,025 |
Wyeth Ayerst Pharmaceuticals | Pfizer | hazardous waste violation | 2004 | EPA | $37,000 |
Pfizer Pharmaceuticals LLC | Pfizer | hazardous waste violation | 2005 | EPA | $55,000 |
Wyeth Rouses Point | Pfizer | water pollution violation | 2008 | EPA | $44,500 |
Wyeth Pharmaceuticals Company, Inc. | Pfizer | water pollution violation | 2010 | EPA | $77,000 |
Pfizer Pharmaceuticals | Pfizer | PCB violation | 2010 | EPA | $24,650 |
Pfizer Pharmaceuticals, LLC | Pfizer | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $728,000 |
KING PHARMACEUTICALS | Pfizer | air pollution violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | environmental violation | 2004 | EPA | $5,000 |
Pharmacia & Upjohn Company | Pfizer | air pollution violation | 2005 | EPA | $676,250 |
Pharmacia and Upjohn Company LLC | Pfizer | environmental violation | 2017 | EPA | $34,170 |
Elan Corporation PLC | Perrigo | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Elan Corporation, plc | Perrigo | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Elan Pharmaceuticals Inc. | Perrigo | export control violation | 2005 | BIS | $31,000 |
Elan Corp. | Perrigo | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Perrigo Company | Perrigo | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
Perrigo Co. | Perrigo | consumer protection violation | 2022 | CA-MULTI | $360,000 |
ELAN PHARMACEUTICALS INC. | Perrigo | workplace safety or health violation | 2003 | OSHA | $7,125 |
ELAN PHARMACEUTICALS INC. | Perrigo | workplace safety or health violation | 2004 | OSHA | $18,225 |
PERRIGO COMPANY OF SOUTH CAROLINA | Perrigo | workplace safety or health violation | 2008 | OSHA | $5,000 |
PBM NUTRITIONALS LLC | Perrigo | workplace safety or health violation | 2021 | OSHA | $14,502 |
PERRIGO COMPANY PLC | Perrigo | workplace safety or health violation | 2023 | OSHA | $12,600 |
Parexel International, LLC | Parexel International | labor relations violation | 2012 | NLRB | $253,000 |
ExecuPharm, Inc. | Parexel International | Family and Medical Leave Act | 2017 | WHD | $5,900 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Pharmavite LLC | Otsuka Pharmaceutical | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | consumer protection violation | 2007 | VT-AG | $10,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | DOJ_CIVIL | $115,874,895 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Pharmavite LLC | Otsuka Pharmaceutical | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
PHARMAVITE CORP | Otsuka Pharmaceutical | workplace safety or health violation | 2001 | OSHA | $18,300 |
PHARMAVITE | Otsuka Pharmaceutical | workplace safety or health violation | 2005 | OSHA | $20,055 |
PHARMAVITE LLC | Otsuka Pharmaceutical | workplace safety or health violation | 2019 | OSHA | $5,775 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Organon USA Inc. | Organon & Co. | drug or medical equipment safety violation | 2018 | private lawsuit-federal | $100,000,000 |
Organon Inc. | Organon & Co. | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
Mia Rose, Inc. | Nutraceutical International Corp. | air pollution violation | 2014 | CA-ARB | $45,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | environmental violation | 2009 | NC-ENV | $36,836 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Novo Nordisk A/S | Novo Holdings A/S | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | workplace safety or health violation | 2003 | OSHA | $5,610 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | environmental violation | 2009 | EPA | $26,797 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | environmental violation | 2016 | EPA | $8,400 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | environmental violation | 2000 | EPA | $5,000 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
Novartis Pharmaceuticals | Novartis | kickbacks and bribery | 2015 | USAO | $390,000,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Chiron Corporation Ltd | Novartis | economic sanction violation | 2004 | OFAC | $168,500 |
Novartis Pharmaceuticals | Novartis | employment discrimination | 2013 | OFCCP | $51,594 |
NOVARTIS PHARMACEUTICALS CORPORATION | Novartis | benefit plan administrator violation | 2006 | EBSA | $10,001 |
Novartis | Novartis | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Novartis Corporation and Alcon Laboratories | Novartis | employment discrimination | 2016 | private lawsuit-federal | $8,000,000 |
Novartis Corporation | Novartis | employment discrimination | 2010 | private lawsuit-federal | $175,000,000 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Geneva Pharmaceuticals | Novartis | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Novartis Pharmaceuticals | Novartis | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
Novartis Pharmaceuticals Corporation | Novartis | kickbacks and bribery | 2020 | CA-AG | $11,800,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
Novartis Hellas S.A.C.I. et al. | Novartis | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
Novartis AG | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $126,850,000 |
Novartis Pharmaceuticals Corporation | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $13,000 |